sonelokimab 
GtoPdb Ligand ID: 10491
|
Synonyms: IL17-MS3086 | IL17MS3086 | SEQ ID 836 [WO2012156219A1]
Compound class:
Antibody
Comment: Sonelokimab (IL17MS3086) is an anti-IL-17A/F single chain camelid nanobody [1]. The peptide sequence for proposed INN sonelokimab is a 100% match for SEQ ID 836 that is claimed in Merck/Ablynx patent WO2012156219A1. IL17MS3086 potently binds to both IL-17A and -F and prevents IL-17R pathway activation (e.g . IL-6 production), and was designed for anti-inflammatory potential. We provide the IL17MS3086 to sonelokimab association in good faith, and await formal disclosure.
|
Classification  |
|
| Compound class | Antibody |
| International Nonproprietary Names |
|
| INN number | INN |
| 11137 | sonelokimab |
| Synonyms |
| IL17-MS3086 | IL17MS3086 | SEQ ID 836 [WO2012156219A1] |
| Database Links |
|
| GtoPdb PubChem SID | 385612250 |
| Search PubMed clinical trials | sonelokimab |
| Search PubMed titles | sonelokimab |
| Search PubMed titles/abstracts | sonelokimab |
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License